☰

Ryan P. Bender, Ph.D. - Publications

Affiliations: 
2007 Vanderbilt University, Nashville, TN 
Area:
Biochemistry, Toxicology

8/30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Bender RP, Jablonksy MJ, Shadid M, Romaine I, Dunlap N, Anklin C, Graves DE, Osheroff N. Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity. Biochemistry. 47: 4501-9. PMID 18355043 DOI: 10.1021/Bi702019Z  0.752
2007 Wilstermann AM, Bender RP, Godfrey M, Choi S, Anklin C, Berkowitz DB, Osheroff N, Graves DE. Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme. Biochemistry. 46: 8217-25. PMID 17580961 DOI: 10.1021/Bi700272U  0.514
2007 Bender RP, Osheroff N. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate. Chemical Research in Toxicology. 20: 975-81. PMID 17516663 DOI: 10.1021/Tx700062T  0.724
2007 Bender RP, Ham AJ, Osheroff N. Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405. Biochemistry. 46: 2856-64. PMID 17298034 DOI: 10.1021/Bi062017L  0.701
2006 Bender RP, Lehmler HJ, Robertson LW, Ludewig G, Osheroff N. Polychlorinated biphenyl quinone metabolites poison human topoisomerase IIalpha: altering enzyme function by blocking the N-terminal protein gate. Biochemistry. 45: 10140-52. PMID 16906772 DOI: 10.1021/Bi0524666  0.662
2005 Lindsey RH, Bender RP, Osheroff N. Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chemico-Biological Interactions. 153: 197-205. PMID 15935817 DOI: 10.1016/J.Cbi.2005.03.035  0.748
2005 Lindsey RH, Bender RP, Osheroff N. Effects of benzene metabolites on DNA cleavage mediated by human topoisomerase II alpha: 1,4-hydroquinone is a topoisomerase II poison. Chemical Research in Toxicology. 18: 761-70. PMID 15833037 DOI: 10.1021/Tx049659Z  0.678
2004 Bender RP, Lindsey RH, Burden DA, Osheroff N. N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison. Biochemistry. 43: 3731-9. PMID 15035644 DOI: 10.1021/Bi036107R  0.731
Low-probability matches (unlikely to be authored by this person)
2012 Kwong LN, Costello JC, Liu H, Jiang S, Helms TL, Langsdorf AE, Jakubosky D, Genovese G, Muller FL, Jeong JH, Bender RP, Chu GC, Flaherty KT, Wargo JA, Collins JJ, et al. Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nature Medicine. 18: 1503-10. PMID 22983396 DOI: 10.1038/Nm.2941  0.14
2015 Vranic S, Marchiò C, Castellano I, Botta C, Scalzo MS, Bender RP, Payan-Gomez C, di Cantogno LV, Gugliotta P, Tondat F, di Celle PF, Mariani S, Gatalica Z, Sapino A. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Human Pathology. 46: 1350-9. PMID 26208846 DOI: 10.1016/j.humpath.2015.05.017  0.109
2014 Gatalica Z, Millis SZ, Vranic S, Bender R, Basu GD, Voss A, Von Hoff DD. Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases. Oncotarget. 5: 12440-7. PMID 25415047 DOI: 10.18632/oncotarget.2574  0.097
2022 Jasra S, Giricz O, Zeig-Owens R, Pradhan K, Goldfarb DG, Barreto-Galvez A, Silver AJ, Chen J, Sahu S, Gordon-Mitchell S, Choudhary GS, Aluri S, Bhagat TD, Shastri A, Bejan CA, ... ... Bender R, et al. High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nature Medicine. PMID 35256801 DOI: 10.1038/s41591-022-01708-3  0.096
2016 Xiu J, Piccioni D, Juarez T, Pingle SC, Hu J, Rudnick J, Fink K, Spetzler DB, Maney T, Ghazalpour A, Bender R, Gatalica Z, Reddy S, Sanai N, Idbaih A, et al. Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies. Oncotarget. PMID 26933808 DOI: 10.18632/Oncotarget.7722  0.092
2016 Friedlander ML, Russell K, Millis S, Gatalica Z, Bender R, Voss A. Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 26937756 DOI: 10.1097/IGC.0000000000000677  0.076
2013 Kuroda N, Maris S, Monzon FA, Tan PH, Thomas A, Petersson FB, Gatalica Z, Ghazalpour A, Bender RP, Grossmann P, Michal M, Svajdler M, Ovcak Z, Hora M, Hes O. Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Human Pathology. 44: 47-54. PMID 22939575 DOI: 10.1016/j.humpath.2012.04.006  0.066
2019 Sridharan A, Schinke CD, Georgiev G, Da Silva Ferreira M, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, Pradhan K, Xia Y, Panjikaran M, Sims G, Bhagat CK, ... Bender R, et al. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias. Blood Advances. 3: 3962-3967. PMID 31805192 DOI: 10.1182/Bloodadvances.2019000731  0.058
2015 Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1. Oncotarget. 6: 19819-25. PMID 26110571 DOI: 10.18632/oncotarget.4378  0.057
2015 Wen W, Chen WS, Xiao N, Bender R, Ghazalpour A, Tan Z, Swensen J, Millis SZ, Basu G, Gatalica Z, Press MF. Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers. The Journal of Molecular Diagnostics : Jmd. 17: 487-95. PMID 26320869 DOI: 10.1016/j.jmoldx.2015.04.003  0.056
2020 Morrison KA, Weinreb RH, Dong X, Toyoda Y, Jin JL, Bender R, Mukherjee S, Spector JA. Facilitated self-assembly of a prevascularized dermal/epidermal collagen scaffold. Regenerative Medicine. PMID 33325258 DOI: 10.2217/rme-2020-0070  0.053
2014 Sirintrapun SJ, Geisinger KR, Cimic A, Snow A, Hagenkord J, Monzon F, Legendre BL, Ghazalpour A, Bender RP, Gatalica Z. Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization Medicine. 93: e81. PMID 25275525 DOI: 10.1097/MD.0000000000000081  0.044
2013 Bender RP, McGinniss MJ, Esmay P, Velazquez EF, Reimann JD. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1320-8. PMID 23599145 DOI: 10.1038/Modpathol.2013.77  0.043
2013 Selzler K, Burack M, Bender R, Mapstone M. Neurophysiological correlates of motor and working memory performance following subthalamic nucleus stimulation Journal of Cognitive Neuroscience. 25: 37-48. PMID 23198889 DOI: 10.1162/Jocn_A_00306  0.033
2015 Millis SZ, Bryant D, Basu G, Bender R, Vranic S, Gatalica Z, Vogelzang NJ. Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin. Clinical Genitourinary Cancer. 13: e37-49. PMID 25178641 DOI: 10.1016/j.clgc.2014.07.010  0.029
2015 Gatalica Z, Vranic S, Ghazalpour A, Xiu J, Ocal IT, McGill J, Bender RP, Discianno E, Schlum A, Sanati S, Palazzo J, Reddy S, Pockaj B. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. Oncotarget. PMID 26625196 DOI: 10.18632/oncotarget.6421  0.027
2008 Krajinovic M, Brukner I, Iqbal O, Bender R, Joshi VA, John T, Tsao MS, Liu G. Further insight into the markers of methotrexate resistance in childhood acute lymphoblastic leukemia patients. Personalized Medicine. 5: 325-329. PMID 29783459 DOI: 10.2217/17410541.5.4.325  0.024
2016 Vranic S, Ghosh N, Kimbrough J, Bilalovic N, Bender R, Arguello D, Veloso Y, Dizdarevic A, Gatalica Z. PD-L1 Status in Refractory Lymphomas. Plos One. 11: e0166266. PMID 27861596 DOI: 10.1371/journal.pone.0166266  0.02
2019 Celie KB, Toyoda Y, Dong X, Morrison KA, Zhang P, Asanbe O, Jin J, Hooper RC, Zanotelli MR, Kaymakcalan O, Bender R, Spector JA. Microstructured Hydrogel Scaffolds Containing Differential Density Interfaces Promote Rapid Cellular Invasion and Vascularization. Acta Biomaterialia. PMID 31004845 DOI: 10.1016/j.actbio.2019.04.027  0.015
2021 Bastawros D, Kaczmarski K, Zhao J, Bender R, Myers E, Tarr ME. Twice-Daily Nitrofurantoin Administration Following Short-term Transurethral Catheterization After Pelvic Reconstructive Surgery: A Randomized Clinical Trial. Female Pelvic Medicine & Reconstructive Surgery. 27: 202-207. PMID 33620905 DOI: 10.1097/SPV.0000000000000977  0.01
2012 Kwong LN, Costello JC, Liu H, Jiang S, Helms TL, Langsdorf AE, Jakubosky D, Genovese G, Muller FL, Jeong JH, Bender RP, Chu GC, Flaherty KT, Wargo JA, Collins JJ, et al. Erratum: Corrigendum: Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma Nature Medicine. 18: 1857-1857. DOI: 10.1038/Nm1212-1857A  0.01
2012 McGinniss MJ, Bender RP, Ghazalpour A. Quality control, assurance, and standardization of molecular diagnostics Principles of Molecular Diagnostics and Personalized Cancer Medicine. 278-289.  0.01
Hide low-probability matches.